Indian Journal of Pathology and Microbiology
Home About us Instructions Submission Subscribe Advertise Contact e-Alerts Ahead Of Print Login 
Users Online: 3334
Print this page  Email this page Bookmark this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others


Immunohistochemical analysis of tumor-infiltrating lymphocytes in breast carcinoma: Relation to prognostic variables

Helal Thanaa E. A., Ibrahim Eman A. A., Alloub Amal I. A.

Year : 2013| Volume: 56| Issue : 2 | Page no: 89-93

   This article has been cited by
1 Interleukin 15 and Eotaxin correlate with the outcome of breast cancer patients vice versa independent of CTC status
Theresa Vilsmaier, Helene Hildegard Heidegger, Lennard Schröder, Elisabeth Trapp, Alaleh Zati zehni, Brigitte Rack, Wolfgang Janni, Sven Mahner, Tobias Weissenbacher, Udo Jeschke, Jan-Niclas Mumm, Theresa Vilsmaier, Helene Hildegard Heidegger, Lennard Schröder
Archives of Gynecology and Obstetrics. 2021; 303(1): 217
[Pubmed]  [Google Scholar] [DOI]
2 Immune microenvironment in different molecular subtypes of ductal breast carcinoma
Mona Sadeghalvad, Hamid-Reza Mohammadi-Motlagh, Nima Rezaei
Breast Cancer Research and Treatment. 2021; 185(2): 261
[Pubmed]  [Google Scholar] [DOI]
3 A Study on Tumor-Infiltrating Lymphocytes in Different Subtypes of Breast Cancer
Polina D. Dimitrova, Savelina L. Popovska, Ivan N. Ivanov
Journal of Biomedical and Clinical Research. 2021; 14(1): 70
[Pubmed]  [Google Scholar] [DOI]
4 The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status
Anna Glajcar,Joanna Szpor,Diana Hodorowicz-Zaniewska,Katarzyna Ewa Tyrak,Krzysztof Okon
Virchows Archiv. 2019; 475(1): 13
[Pubmed]  [Google Scholar] [DOI]
5 New Insights into Tumor-Infiltrating B Lymphocytes in Breast Cancer: Clinical Impacts and Regulatory Mechanisms
Meng Shen,Jian Wang,Xiubao Ren
Frontiers in Immunology. 2018; 9
[Pubmed]  [Google Scholar] [DOI]
6 Folate receptor a is associated with poor clinicopathological perspectives in breast carcinoma
Noha Abd ElRahim Aboulhagag,Rana Fathy Torky,Sabah Ahmed Fadel
Pathophysiology. 2018; 25(1): 71
[Pubmed]  [Google Scholar] [DOI]
7 Yin-yang effect of tumor infiltrating B cells in breast cancer: From mechanism to immunotherapy
Zhigang Zhang,Ying Zhu,Zhen Wang,Ting Zhang,Pin Wu,Jian Huang
Cancer Letters. 2017; 393: 1
[Pubmed]  [Google Scholar] [DOI]
8 PD-L1 mediated the differentiation of tumor-infiltrating CD19+B lymphocytes and T cells in Invasive breast cancer
Honggeng Guan,Yang Lan,Yuqiu Wan,Qin Wang,Cheng Wang,Longjiang Xu,Yongjing Chen,Wenting Liu,Xueguang Zhang,Yecheng Li,Yongping Gu,Zemin Wang,Fang Xie
OncoImmunology. 2016; 5(2): e1075112
[Pubmed]  [Google Scholar] [DOI]
9 CD8+ tumor infiltrating lymphocytes strongly correlate with molecular subtype and clinico-pathological characteristics in breast cancer patients from Sudan
Mahmoud Mohamed,Hina Sarwath,Nada Salih,Devendra Bansal,Prem Chandra,Nazik E. Husain,Lotfi Chouchane,Ali A. Sultan,Shahinaz Bedri
Translational Medicine Communications. 2016; 1(1)
[Pubmed]  [Google Scholar] [DOI]
10 Prediction of chemotherapeutic efficacy using the ratio of neutrophils to lymphocytes in patients with unresectable or recurrent gastric cancer
Oncology Letters. 2015; 10(4): 2244
[Pubmed]  [Google Scholar] [DOI]
11 Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
Koo Si-Lin,Loh Kiley,Sulastri Kamis,Jabed Iqbal,Rebecca Dent,Yap Yoon Sim
Current Breast Cancer Reports. 2015; 7(4): 232
[Pubmed]  [Google Scholar] [DOI]


Read this article